Women in Breast Cancer: 2022, volume II

80.3K

views

154

authors

18

articles

Women in Breast Cancer: 2022, volume II

80.3K

views

154

authors

18

articles

Editors

4

Margaret Gatti-Mays

Pelotonia Institute for Immuno-Oncology, Comprehensive Cancer Center, The Ohio State University

Rachel Wuerstlein

Ludwig Maximilian University of Munich

Ariella Hanker

University of Texas Southwestern Medical Center

Svasti Haricharan

Sanford Burnham Prebys Medical Discovery Institute

Impact

About

We are delighted to present the Frontiers in Oncology "Women in Breast Cancer” Volume II series of article collections.

At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.

Therefore, Frontiers in Oncology is proud to offer this platform to promote the work of women scientists, across all fields of Oncology.

The work presented here highlights the diversity of research performed across the entire breadth of Oncology research and presents advances in theory, experiment, and methodology with applications to compelling problems.

Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.

All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.

Download ebook

PDF

EPUB

Share

Editors

Margaret Gatti-Mays

Pelotonia Institute for Immuno-Oncology, Comprehensive Cancer Center, The Ohio State University

Rachel Wuerstlein

Ludwig Maximilian University of Munich

Ariella Hanker

University of Texas Southwestern Medical Center

Svasti Haricharan

Sanford Burnham Prebys Medical Discovery Institute

Impact

80,260 Total views

63,793 Article views

14,911 Article downloads

1,556 Topic views

Published In

Frontiers in Oncology

Breast Cancer

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic